[1] LI Z, CHEN Y, ZULIPIKAER M, et al. Identification of PSMB9 and CXCL13 as Immune-related Diagnostic Markers for Rheumatoid Arthritis by Machine Learning.Curr Pharm Des. 2022;28(34):2842-2854.
[2] JANG S, KWON EJ, LEE JJ. Rheumatoid Arthritis:Pathogenic Roles of Diverse Immune Cells. Int J Mol Sci. 2022;23(2):905.
[3] 宋世雷,陈跃平,陈锋.基于生物信息与机器学习分析类风湿关节炎疾病特征基因与免疫细胞的关系[J].中国免疫学杂志,2023,39(12):2470-2476.
[4] KARAMI J, ASLANI S, JAMSHIDI A, et al. Genetic implications in the pathogenesis of rheumatoid arthritis:an updated review.Gene. 2019;702:8-16.
[5] 钱晓芬,曾平,刘金富,等.差异表达基因联合加权共表达网络分析筛选骨关节炎滑膜中的关键基因 [J].中国组织工程研究,2022,26(33):5342-5349.
[6] 李文静,杨杰,陈冬梅.WGCNA与机器学习算法识别结直肠癌发病机制中潜在PANoptosis关键基因[J].东南大学学报(医学版),2023,42(5):688-696.
[7] GUO S, WU J, ZHOU W, et al.Identification and analysis of key genes associated with acute myocardial infarction by integrated bioinformatics methods.Medicine(Baltimore).2021;100(15):e25553.
[8] AKI T, HASHIMOTO K, OGASAWARA M, et al. A whole-genome transcriptome analysis of articular chondrocytes in secondary osteoarthritis of the hip. PLoS One. 2018; 13(6):e0199734.
[9] LI G, LI X, YANG M, et al. Prediction of biomarkers of oral squamous cell carcinoma using microarray technology. Sci Rep. 2017; 7:42105.
[10] 李慧月,王沐榛,喻叶,等.加权基因共表达网络分析筛选胰腺癌肿瘤免疫相关基因[J].华南师范大学学报(自然科学版), 2021,53(6):61-67.
[11] AUWUL MR, RAHMAN MR, GOV E, et al. Bioinformatics and machine learning approach identifies potential drug targets and pathways in COVID-19. Brief Bioinform. 2021;22(5):bbab120.
[12] 刘孝生,魏东升,何信用,等.基于综合生物信息学和机器学习算法构建衰老相关分泌表型的骨关节炎预测模型[J].中国医科大学学报,2023,53(12):1092-1097.
[13] KANG K, XIE F, MAO J, et al. Significance of tumor mutation burden in immune infiltration and prognosis in cutaneous melanoma. Front Oncol. 2020;10:573141
[14] 范氏绒.昆断益母方调控Treg/Th17细胞失衡和抗类风湿关节炎的机制研究[D].广州:广州中医药大学,2021.
[15] LIN YJ, ANZAGHE M, SCHÜLKE S. Update on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis.Cells. 2020;9(4):880.
[16] 董文哲,刘健,端淑杰.新风胶囊通过调节SOCS1/STAT3/miR326改善类风湿关节炎患者Th17/Treg失衡状态[J].免疫学杂志,2018,34(6):499-506.
[17] ZHANG W, XIE X, HUANG Z, et al. The integration of single-cell sequencing, TCGA, and GEO data analysis revealed that PRRT3-AS1 is a biomarker and therapeutic target of SKCM. Front Immunol. 2022;13: 919145.
[18] CHOI RY, COYNER AS, KALPATHY-CRAMER J, et al. Introduction to Machine Learning, Neural Networks,and Deep Learning. Transl Vis Sci Technol. 2020;9(2):14.
[19] YANG Y, YI X, CAI Y, et al. Immune-Associated Gene Signatures and Subtypes to Predict the Progression of Atherosclerotic Plaques Based on Machine Learning. Front Pharmacol. 2022;13:865624
[20] 夏天,李炳霖,肖发源,等.类风湿关节炎铁死亡特征基因 CeRNA 网络构建及免疫表现[J].中国组织工程研究,2024, 28(16):2561-2567.
[21] SUN H, PENG G, CHEN K, et al. Identification of EGFR as an essential regulator in chondrocytes ferroptosis of osteoarthritis using bioinformatics,in vivo,and in vitro study. Heliyon. 2023;9(9):e19975.
[22] 史阳.TNS3及其相关超级增强子在LMK-235抑制食管鳞状细胞癌增殖中的机制研究[D].郑州:郑州大学,2021.
[23] WU Y, ZHANG HQ, TANG M, et al. Abnormal TNS3 gene methylation in patients with congenital scoliosis. BMC Musculoskelet Disord. 2022;23(1):797.
[24] TOUAITAHUATA H, MOREL A, URBACH S, et al.Tensin 3 is a new partner of Dock5 that controls osteoclast podosome organization and activity. J Cell Sci. 2016;129(18):3449-3461.
[25] 路帅,李文杰,徐紫薇,等.乳腺癌关键基因SDC1的临床预后意义及其与M1型巨噬细胞相关性分析[J].齐齐哈尔医学院学报,2023,44(11):1001-1010.
[26] 李哲杰.SDC1通过外排EGFR抑制食管癌恶性进展分子机制研究[D].济宁:济宁医学院,2023.
[27] MEYER A, SIENES RE, NIJIM W, et al. Syntenin-1-mediated arthritogenicity is advanced by reprogramming RA metabolic macrophages and Th1 cells. Ann Rheum Dis. 2023;82(4):483-495.
[28] ALZOUBI O, MEYER A, GONZALEZ TP, et al. Significance of IL-34 and SDC-1 in the pathogenesis of RA cells and preclinical models. Clin Immunol. 2023;251:109635.
[29] CHEN D, LIU J, ZANG L, et al. Integrated machine learning and bioinformatic analyses constructed a novel stemness-related classifier to predict prognosis and immunotherapy responses for hepatocellular carcinoma patients. Int J Biol Sci. 2022;18(1):360-373.
[30] LIU Z, MI M, LI X, et al. A lncRNA prognostic signature associated with immune infiltration and tumour mutation burden in breast cancer. J Cell Mol Med. 2020;24(21):12444-12456. |